Trial Profile
A retrospective study of febuxostat in the treatment of hyperuricemia in patients with severe renal impairment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Feb 2016
Price :
$35
*
At a glance
- Drugs Febuxostat (Primary)
- Indications Hyperuricaemia
- Focus Therapeutic Use
- 01 Feb 2016 New trial record